Smith & Nephew plc ADR (SNN)

Schlusskurs vom Vortag:

$24.44

Offen:

$25.09

24-Stunden-Volumen:

1.06M

Marktkapitalisierung:

$10.83B

Einnahmen:

$5.55B

Nettoeinkommen (Verlust:

$263.00M

KGV:

49.56

EPS:

0.5

Netto-Cashflow:

-

1W Leistung:

+1.35%

1M Leistung:

+0.69%

6M Leistung:

+2.91%

1J Leistung:

-22.88%

1-Tages-Spanne:

$24.71

$25.16

52-Wochen-Spanne:

$21.52

$32.70

Smith & Nephew plc ADR Stock (SNN) Company Profile

Firmenname

Smith & Nephew plc ADR

Sektor

Healthcare (1213)

Branche

Medical Devices (160)

Telefon

44 20 7401 7646

Adresse

15 Adam Street, London

Mitarbeiter

15,000

Twitter

@smithnephewplc

Nächster Verdiensttermin

Neueste SEC-Einreichungen

SNN's Discussions on Twitter

Smith & Nephew plc ADR Stock (SNN) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2023-11-28	Hochstufung	Barclays	Underweight → Equal Weight
2023-11-03	Hochstufung	JP Morgan	Neutral → Overweight
2023-10-31	Hochstufung	HSBC Securities	Hold → Buy
2023-10-13	Eingeleitet	Stifel	Hold
2023-08-08	Hochstufung	UBS	Sell → Neutral
2023-04-27	Herabstufung	HSBC Securities	Buy → Hold
2023-04-11	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2022-12-12	Eingeleitet	Citigroup	Buy
2022-11-28	Herabstufung	UBS	Neutral → Sell
2022-10-18	Eingeleitet	Morgan Stanley	Equal-Weight
2022-07-28	Herabstufung	Canaccord Genuity	Buy → Hold
2022-03-16	Eingeleitet	RBC Capital Mkts	Outperform
2022-03-15	Eingeleitet	RBC Capital Mkts	Outperform
2022-03-04	Hochstufung	Redburn	Sell → Neutral
2021-06-09	Hochstufung	Credit Suisse	Neutral → Outperform
2020-12-18	Hochstufung	Bernstein	Mkt Perform → Outperform
2020-12-01	Eingeleitet	Barclays	Overweight
2020-07-29	Hochstufung	BofA Securities	Neutral → Buy
2020-06-04	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2020-04-14	Herabstufung	Citigroup	Buy → Neutral
2019-11-21	Eingeleitet	Citigroup	Buy
2019-11-12	Eingeleitet	Bernstein	Outperform
2019-07-23	Hochstufung	Berenberg	Hold → Buy
2019-02-08	Herabstufung	Exane BNP Paribas	Outperform → Neutral
2019-01-02	Herabstufung	JP Morgan	Overweight → Neutral
2018-12-10	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2018-11-01	Bestätigt	Canaccord Genuity	Buy
2018-01-25	Hochstufung	JP Morgan	Neutral → Overweight
2017-12-11	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2017-10-11	Eingeleitet	Canaccord Genuity	Buy
2017-02-27	Herabstufung	Goldman	Buy → Neutral
2017-01-19	Eingeleitet	HSBC Securities	Hold
2016-12-08	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2016-10-06	Herabstufung	Berenberg	Buy → Hold
2016-02-26	Eingeleitet	Cantor Fitzgerald	Hold

Alle ansehen

Smith & Nephew plc ADR Aktie (SNN) Neueste Nachrichten

Smith+Nephew (SNN) Expands in Australia With New Alliance

Zacks Investment Research

Smith+Nephew signs exclusive distribution agreement to provide unique NAVBIT SPRINT™ solution in Australia

GlobeNewswire Inc.

Smith+Nephew’s PICO™ Single Use Negative Pressure Wound Therapy System provides better clinical outcomes versus standard of care according to UK National Institute for Health and Care Excellence (NICE)

GlobeNewswire Inc.

Smith+Nephew introduces the RENASYS™ EDGE Negative Pressure Wound Therapy System – an exciting new option in home-based care for patients living with chronic wounds

GlobeNewswire Inc.

Fresenius Medical (FMS) to Unveil Training on Augmented Reality

Zacks Investment Research

Smith+Nephew teams up with UFC to be first-ever Preferred Sports Medicine Technology Partner

GlobeNewswire Inc.

Finanzdaten der Smith & Nephew plc ADR-Aktie (SNN)

Smith & Nephew plc ADR (SNN) Umsatz 2024

Smith & Nephew plc ADR (SNN) Nettogewinn 2024

Smith & Nephew plc ADR (SNN) Gewinn je Aktie 2024